Related Experiment Video
Updated: Aug 16, 2025

07:32
Preparation of Mycobacterium Tuberculosis Culture Filtrate to Understand TB Pathogenesis
Published on: March 28, 2025
541
A protein signature associated with active tuberculosis identified by plasma profiling and network-based analysis
Zaynab Mousavian1,2,3, Elin Folkesson1,4, Gabrielle Fröberg1,5
1Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.
Iscience
|December 23, 2022
Summary
Researchers identified a 12-protein signature in plasma that accurately detects active tuberculosis (TB). This discovery could lead to faster, non-sputum diagnostic tests, aiding in controlling TB transmission.
Area of Science:
- Immunology
- Infectious Diseases
- Biomarker Discovery
Background:
- Tuberculosis (TB) affects millions globally, with high mortality and transmission rates.
- Current diagnostic methods often rely on sputum, leading to delays and continued spread.
- Novel diagnostic biomarkers are crucial for timely intervention and disease control.
Purpose of the Study:
- To identify plasma protein biomarkers associated with active tuberculosis (TB).
- To develop a potential non-sputum-based diagnostic signature for TB.
Main Methods:
- Assessed plasma protein levels (n=92) in individuals with active TB, latent TB, and healthy controls.
- Utilized co-expression network analysis to identify TB-associated protein modules.
- Filtered protein modules to establish a robust 12-protein signature.
Main Results:
- A specific module of proteins strongly correlated with active TB was identified.
- A 12-protein plasma signature was established, excluding low-abundance or non-TB-related proteins.
- This signature showed high enrichment in both pulmonary and extrapulmonary TB cases and correlated with disease severity.
Conclusions:
- A 12-protein plasma signature serves as a promising biomarker for active TB detection.
- This signature could facilitate the development of novel, non-sputum-based diagnostic tools.
- Early and accurate TB diagnosis via these biomarkers may help reduce disease transmission.
Related Concept Videos
Pulmonary Tuberculosis IV
186
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
186
Pulmonary Tuberculosis III
410
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
410
Pulmonary Tuberculosis I
297
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
Pulmonary Tuberculosis V
225
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
225
Pulmonary Tuberculosis II
296
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
296

